Over the past decade, there has been an emergence of commercially available home devices to help monitor an infant’s vital signs during sleep. These devices aim to provide reassurance and peace of ...

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option. A new Phase-3b study has found that ...

The newly-approved indication is for children aged 4 years and older who weigh 33 < 66 lbs, expanding on the August 9, 2024 approval in children at least 66 lbs. As of March 5, 2025, epinephrine nasal ...

Mike Hennessy Jr, President and CEO of MJH Life Sciences kicks off our March Mental Health issue with a look into the ongoing pediatric mental health crisis. The pediatric mental health crisis in the ...

Puzzler poll: Urticarial rash in a 9-hours-old male ...

Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants. New data from the CHORD trial (NCT05788536) ...

After 9.5 months, 94% of participants reported an improvement in incontinence symptoms, with 58% experiencing complete resolution and 18 (36%) reporting greater than 50% reduction in the number of ...

According to data presented at AAAAI, berotralstat demonstrated a well tolerated safety profile and early and sustained reductions in monthly HAE attacks among patients aged 2 to under 12 years.

CDC: Most US teens fail to get recommended 8 hours of sleep, report finds ...

Despite decreases of invalid vaccine doses, series completion still lacks ...

Despite decreases of invalid vaccine doses, series completion still lacks ...

Despite decreases of invalid vaccine doses, series completion still lacks ...